U.S. Securities & Exchange Commission
SEC Seal
Home | Search Home | Latest Filings | Previous Page
U.S. Securities and Exchange Commission


Fairmount Healthcare Fund L.P. (0001686157)
State location: PA | State of Inc.: DE | Fiscal Year End: 1231
Business Address
200 BARR HARBOR DRIVE
SUITE 400
WEST CONSHOHOCKEN PA 19428
(267) 760-4066
Mailing Address
200 BARR HARBOR DRIVE
SUITE 400
WEST CONSHOHOCKEN PA 19428
Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.)

Issuer Filings Transaction Date Type of Owner
Apogee Therapeutics, Inc. 0001974640 2023-07-13 director
Aeglea BioTherapeutics, Inc.
Current Name:Spyre Therapeutics, Inc.
0001636282 2023-06-22 director, 10 percent owner
SIGNAL GENETICS, INC.
Current Name:Viridian Therapeutics, Inc.\DE
0001590750 2020-10-27 director, other: See Remarks


Items 1 - 0

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition Transaction Date Deemed Execution Date Issuer Form Transaction Type Direct or Indirect Ownership Number of Securities Transacted Number of Securities Owned Line Number Issuer CIK Security Name

http://www.sec.gov/cgi-bin/own-disp


Modified: 04/22/2016